Fang Liu

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

High Impact

Researcher

NCTR

Faculty Researcher

26 h-index 89 pubs 2,742 cited

Research Areas

Biomedical Subjects

Links

ORCID Research Group

OverviewAI-generated summary

Fang Liu's research program focuses on understanding and mitigating neurotoxicity, with a particular emphasis on the potential of natural products and other therapeutic strategies for neurodegenerative diseases. Liu has investigated the neuroprotective effects of carnitine and explored natural products as potential treatments for these conditions. This work involves the development and application of screening tools to assess the neurotoxic potential of botanicals, contributing to strategies for evaluating the safety of such substances.

Further research extends to the impact of various agents on neural stem cells and the brain. This includes examining the effects of cannabidiol and its metabolites on human neural stem cells and developing primate models to evaluate the impact of ketamine and surgical stress on the neonatal brain. Liu's work also touches upon broader health topics, including the role of the gut microbiota in non-alcoholic fatty liver disease and the signaling pathways of the innate immune system in behavioral changes. Liu is a highly cited researcher with an h-index of 26, having published 89 total publications with 2,742 citations.

Metrics

h-index: 26
Publications: 89
Citations: 2,742

Selected Publications

Regulating controlled substances to advance research and protect public health (2026)

Current Opinion in Toxicology 1 citation DOI OpenAlex
Assessing the developmental effects of fentanyl and impacts on lipidomic profiling using neural stem cell models (2025)

Experimental Biology and Medicine 2 citations DOI OpenAlex
The effects of cannabidiol and its main metabolites on human neural stem cells (2025)

Experimental Biology and Medicine 4 citations DOI OpenAlex
Assessing potential desflurane-induced neurotoxicity using nonhuman primate neural stem cell models (2025)

Experimental Biology and Medicine 2 citations DOI OpenAlex
Biomarkers of Neurotoxicity and Disease (2025)

Elsevier eBooks 1 citation DOI OpenAlex
Screening tools to evaluate the neurotoxic potential of botanicals: building a strategy to assess safety (2024)

Expert Opinion on Drug Metabolism & Toxicology 7 citations DOI OpenAlex
Establishment of neural stem cells from fetal monkey brain for neurotoxicity testing (2023)

Experimental Biology and Medicine 3 citations DOI OpenAlex
Development of a primate model to evaluate the effects of ketamine and surgical stress on the neonatal brain (2023)

Experimental Biology and Medicine 4 citations DOI OpenAlex
The NMDA Receptor System and Developmental Neurotoxicity (2022)

1 citation DOI OpenAlex
Phencyclidine (PCP)-induced neurotoxicity and behavioral deficits (2022)

Advances in neurotoxicology DOI OpenAlex
The NMDA Receptor System and Developmental Neurotoxicity (2021)

DOI OpenAlex
Neuroprotective Effects of Carnitine and Its Potential Application to Ameliorate Neurotoxicity (2021)

Chemical Research in Toxicology 21 citations DOI OpenAlex
Application of microRNA profiling to understand sevoflurane-induced adverse effects on developing monkey brain (2020)

NeuroToxicology 6 citations DOI OpenAlex
Neurotoxicity of drug of abuse (2020)

NeuroToxicology DOI OpenAlex
Potential mechanisms for phencyclidine/ketamine-induced brain structural alterations and behavioral consequences (2019)

NeuroToxicology 12 citations DOI OpenAlex